Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET)

Clinical trial NCT01446744 · UNKNOWN

Trial details

NCT number: NCT01446744
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Tumors

Start date: 2011-11-01
Primary completion: 2026-06-01
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.